U.S. Pharmaceutical Sales - Q3 2013

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2013. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q3 2013 by Sales

Rank Drug Sales ($000)
1 Abilify
Otsuka Pharmaceutical Co.
-1.91% Stats
2 Nexium
AstraZeneca Pharmaceuticals
4.89% Stats
3 Humira
AbbVie, Inc.
4.90% Stats
4 Cymbalta
Eli Lilly and Company
3.31% Stats
5 Crestor
AstraZeneca Pharmaceuticals
-1.17% Stats
6 Advair Diskus
GlaxoSmithKline
-2.11% Stats
7 Enbrel
Amgen Inc.
2.16% Stats
8 Remicade
Centocor Ortho Biotech, Inc
2.60% Stats
9 (1) Neulasta
Amgen Inc.
4.38% Stats
10 (1) Copaxone
Teva Pharmaceuticals
-4.29% Stats
11 Rituxan
Genentech, Inc (member of Roche group)
-4.46% Stats
12 (3) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
12.47% Stats
13 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
3.45% Stats
14 (1) Atripla
Gilead Sciences, Inc.
-5.24% Stats
15 (1) Januvia
Merck & Co., Inc.
-2.33% Stats
16 Avastin
Genentech, Inc (member of Roche group)
-1.41% Stats
17 (1) Lantus
Sanofi (formerly Sanofi Aventis)
6.49% Stats
18 (1) Lyrica
Pfizer Inc
6.13% Stats
19 (2) OxyContin
-3.01% Stats
20 (1) Epogen
Amgen Inc.
3.80% Stats
21 (1) Celebrex
Pfizer Inc
3.46% Stats
22 (2) Truvada
Gilead Sciences, Inc.
-1.67% Stats
23 Diovan
Novartis Corporation
-2.52% Stats
24 (2) Herceptin
Genentech, Inc (member of Roche group)
-0.30% Stats
25 (1) Gleevec
Novartis Corporation
-1.68% Stats
26 (1) Lucentis
Genentech, Inc (member of Roche group)
2.52% Stats
27 (2) Namenda
Forest Pharmaceuticals, Inc
-1.52% Stats
28 (1) Zetia
Merck & Co., Inc.
7.25% Stats
29 (1) Vyvanse
Shire US Inc
1.65% Stats
30 (4) Levemir
Novo Nordisk Inc.
6.54% Stats
31 (1) OneTouch
1.72% Stats
32 (2) Symbicort
AstraZeneca Pharmaceuticals
-3.15% Stats
33 (6) NovoLog FlexPen
Novo Nordisk Inc.
4.54% Stats
34 (2) AndroGel
AbbVie, Inc.
-3.42% Stats
35 (5) Novolog
Novo Nordisk Inc.
3.66% Stats
36 (1) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
-2.46% Stats
37 () Tecfidera
Biogen Idec
Stats
38 (5) enoxaparin
Generic
-12.31% Stats
39 (4) methylphenidate
Generic
-9.31% Stats
40 (9) Lidoderm
Endo Pharmaceuticals
-16.57% Stats
41 (3) Rebif
-8.17% Stats
42 (3) Viagra
Pfizer Inc
2.13% Stats
43 (5) Humalog
Eli Lilly and Company
4.25% Stats
44 () Fluzone
Stats
45 (4) Avonex
Biogen Idec
-6.68% Stats
46 (4) Alimta
Eli Lilly and Company
-5.87% Stats
47 (4) Seroquel XR
AstraZeneca Pharmaceuticals
-5.86% Stats
48 (1) ProAir HFA
Teva Pharmaceuticals
0.09% Stats
49 (2) Victoza
Novo Nordisk Inc.
4.95% Stats
50 (21) Xarelto
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
25.74% Stats
51 (4) Procrit
Janssen Pharmaceuticals, Inc
5.08% Stats
52 (4) Cialis
Eli Lilly and Company
5.58% Stats
53 (1) Gilenya
Novartis Corporation
0.49% Stats
54 (10) Nasonex
Merck & Co., Inc.
-11.64% Stats
55 (9) doxycycline
Generic
-9.45% Stats
56 () Gardasil
Merck & Co., Inc.
Stats
57 (2) Restasis
Allergan, Inc
1.73% Stats
58 (8) Lovaza
GlaxoSmithKline
-4.96% Stats
59 (1) acetaminophen/hydrocodone
Generic
-1.27% Stats
60 (3) Isentress
Merck & Co., Inc.
-2.06% Stats
61 (1) Prezista
Janssen Pharmaceuticals, Inc
-1.67% Stats
62 (6) Stelara
7.67% Stats
63 (14) Niaspan
Abbott Laboratories
-11.30% Stats
64 Orencia
Bristol-Myers Squibb Company
-0.26% Stats
65 (2) Neupogen
Amgen Inc.
1.60% Stats
66 Janumet
Merck & Co., Inc.
0.39% Stats
67 (14) amphetamine/dextroamphetamine
Generic
-9.43% Stats
68 (6) Renvela
Genzyme Corporation
11.34% Stats
69 (15) Flovent HFA
GlaxoSmithKline
-9.90% Stats
70 (8) fenofibrate
Generic
-5.85% Stats
71 (2) VESIcare
Astellas Pharma US
2.40% Stats
72 (2) Dexilant
Takeda Pharmaceuticals North America, Inc
0.15% Stats
73 (8) Reyataz
Bristol-Myers Squibb Company
-7.09% Stats
74 () EpiPen 2-Pak
Stats
75 (2) Synthroid
Abbott Laboratories
7.00% Stats
76 (5) Humalog KwikPen
7.41% Stats
77 (5) Lunesta
Sunovion Pharmaceuticals Inc.
7.57% Stats
78 (17) budesonide
Generic
-13.96% Stats
79 (16) metoprolol
Generic
-12.86% Stats
80 (8) Vytorin
Merck & Co., Inc.
-3.87% Stats
81 (2) Evista
Eli Lilly and Company
2.22% Stats
82 (2) Aranesp
Amgen Inc.
1.83% Stats
83 (5) Xolair
0.07% Stats
84 (11) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
-2.91% Stats
85 () Combivent Respimat
Stats
86 (2) Zytiga
Centocor Ortho Biotech, Inc
2.89% Stats
87 (11) Benicar
Daiichi Sankyo
-3.74% Stats
88 (3) Prevnar 13
Wyeth
2.75% Stats
89 (1) Invega Sustenna
Janssen Pharmaceuticals, Inc
5.47% Stats
90 (4) Xgeva
Amgen Inc.
1.10% Stats
91 Sensipar
Amgen Inc.
3.44% Stats
92 Avonex Pen
Biogen Idec
1.74% Stats
93 (6) Betaseron
Bayer Healthcare Pharmaceuticals
-1.62% Stats
94 (11) Aciphex
Eisai Corporation
-6.83% Stats
95 (6) Xeloda
Roche Pharmaceuticals
-2.33% Stats
96 (4) Afinitor
Novartis Corporation
5.45% Stats
97 (2) fentanyl
Generic
-1.82% Stats
98 (10) modafinil
Generic
-5.45% Stats
99 () Zostavax
Merck & Co., Inc.
Stats
100 (7) Adderall XR
Shire US Inc
-5.66% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)